Journal article
Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer
Brachytherapy, v 12(3), pp 248-253
01 May 2013
PMID: 23453679
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
PURPOSE: The tolerance and complication rates of the urethra are unknown for the interstitial high-dose-rate brachytherapy (HDR-BT) for vaginal cancer.
METHODS AND MATERIALS: Patients with vaginal cancer near/involving the urethra who were treated with HDR-BT between 2008 and 2011 were included. Patients received mean external beam dose of 48.0 Gy followed by mean HDR-BT dose of 4.5 Gy/fraction for five fractions. With CT-based planning, the urethra was contoured from the bladder neck to the meatus. Doses were converted to the biologically equivalent dose in 2 Gy/fraction (EQD(2)).
RESULTS: A total of 16 patients were included, and the EQD(2) D-90 was 74.9 Gy. The urethral volume was 1.31 cm(3), and the EQD(2) to 0.1 and 1 cm(3) were 76.2 and 48.9 Gy, respectively. Two of the 6 patients with urethral involvement developed urethral necrosis. The D-90 for these 2 patients was 76.8 Gy, and the urethral doses to 0.1 and 1 cm(3) were 95.1 and 45.8, respectively. Those who developed severe urethral toxicity had a trend to urethral EQD(2) (95.1 Gy vs. 73.4 Gy, p = 0.1) and significantly higher dose per fraction of HDR-BT to 0.1 cm(3) of the urethra (5.7 Gy vs. 3.7 Gy, p = 0.02) when compared with those who did not develop severe urethral toxicity.
CONCLUSIONS: This study is among the first to assess urethral dosimetry for patients treated with HDR-BT for vaginal cancer. Patients who received five fractions of higher than 5 Gy/fraction to 0.1 cm(3) of urethra (estimated EQD(2) of 85 Gy) are at increased risk of severe urethral toxicity. (C) 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
Metrics
Details
- Title
- Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer
- Creators
- Malolan S. Rajagopalan - UPMC Hillman Cancer CenterNeeta Kannan - University of PittsburghHayeon Kim - University of PittsburghChristopher J. Houser - University of PittsburghSushil Beriwal - University of Pittsburgh
- Publication Details
- Brachytherapy, v 12(3), pp 248-253
- Publisher
- Elsevier
- Number of pages
- 6
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000318333800013
- Scopus ID
- 2-s2.0-84876741576
- Other Identifier
- 991021897261904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging